Organonickel complexes containing α-diimine ligands [Ni(C6F5)2(N∧N)] (N∧N = 2,2′-bipyridine (bpy), 2,9-dimethyl-1,10-phenanthroline (dmphen), 3,4,7,8-tetramethyl-1,10-phenanthroline (tmphen), dipyrido[3,2-a:2′,3′-c]phenazine (dppz), 1,4-bis(isopropyl)-1,4-diazabutadiene (iPr-DAB), and 1,4-bis(2,6-dimethylphenyl)-1,4-diazabutadiene (Xyl-DAB) were prepared and studied structurally, spectroscopically, and electrochemically. Their molecular structures from single-crystal X-ray diffraction show near-perfect square planar Ni(II) coordination except in the case of dmphen. Primary reversible electrochemical reductions in the range from −1 to −2 V vs ferrocene/ferrocenium couple lead to mainly diimine-localized radical anion complexes, while secondary reductions in the range from −2 to −2.5 V lead to dianion complexes, as shown through spectroelectrochemistry. Irreversible metal-centered oxidations at around 0.7 V result in rapid aryl–aryl reductive elimination and formation of decafluorobiphenyl. No photoluminescence was detected for the complexes containing chromophoric α-diimine ligands at room temperature. At 77 K in frozen glassy 2-Me-THF matrices, weak photoluminescence was detected for the dmphen and tmphen derivatives, with broad emission bands peaking around 570 nm. All results are rationalized with the support of (TD-)DFT calculations, highlighting the role of the C6F5 ligand in different systems.
No takes yet. Share an insight, caveat, or question.
Jordan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: